Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Biorelate Logo
Biorelate Growth Score
44
CB Rank
54768
Heat Score
51
Biorelate provides biomedical research services.
Founded
obfuscation
PrivateSeries A Manchester, Manchester, United Kingdom11-50 biorelate.com/
Big Data
Biotechnology
Health Care
Life Science
Medical
Overview

Biorelate
Total Funding
obfuscation
Growth Score
44
Heat Score
51

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score44
-3 pts
in past quarter
Heat Score 51
-1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Biorelate

CB Rank
54768
Biorelate provides biomedical research services.
Founded
obfuscation
PrivateSeries A Manchester, Manchester, United Kingdom11-50 biorelate.com/
Big Data
Biotechnology
Health Care
Life Science
Medical

Funding Rounds

Series A
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Biorelate Limited
Operating Status Active
Company Type For Profit
Founders  Daniel Jamieson
About the Company
Biorelate provides biomedical research services. It engages in the research of biomarkers for the diagnosis of prostate cancer; target validation; and new drug development services. Daniel Jamison founded Biorelate in 2014. It has its headquarters in Oldham in the United Kingdom.
Contact Email info@biorelate.com
Predictions & Insights

Growth Insight

See this Growth Insight
Biorelate is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Galactic AI™
A data curation platform that extracts and organizes cause-and-effect relationships from biomedical literature to support drug discovery and research.
Knowledge Graphs
A structured representation of biomedical cause-and-effect relationships and contextual data points derived from curated literature.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Biorelate Logo
Series A - Biorelate
6
obfuscation
Maven Capital Partners, YFM Equity PartnersSeries A
obfuscation
Series A - Biorelate Logo
Series A - Biorelate
6
obfuscation
Maven Capital Partners, YFM Equity PartnersSeries A
obfuscation
Series A - Biorelate Logo
Series A - Biorelate
6
obfuscation
Maven Capital Partners, YFM Equity PartnersSeries A
obfuscation
Series A - Biorelate Logo
Series A - Biorelate
6
obfuscation
Maven Capital Partners, YFM Equity PartnersSeries A
obfuscation
Series A - Biorelate Logo
Series A - Biorelate
6
obfuscation
Maven Capital Partners, YFM Equity PartnersSeries A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Biorelate Logo
Series A - Biorelate
6
obfuscation
Maven Capital Partners, YFM Equity PartnersSeries A
obfuscation
Series A - Biorelate Logo
Series A - Biorelate
6
obfuscation
Maven Capital Partners, YFM Equity PartnersSeries A
obfuscation
Series A - Biorelate Logo
Series A - Biorelate
6
obfuscation
Maven Capital Partners, YFM Equity PartnersSeries A
obfuscation
Series A - Biorelate Logo
Series A - Biorelate
6
obfuscation
Maven Capital Partners, YFM Equity PartnersSeries A
obfuscation
Series A - Biorelate Logo
Series A - Biorelate
6
obfuscation
Maven Capital Partners, YFM Equity PartnersSeries A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Manchester Tech Trust Angels Logo
Manchester Tech Trust Angels
—
Series A - Biorelate Logo
Series A - Biorelate
—
Manchester Tech Trust Angels Logo
Manchester Tech Trust Angels
—
Series A - Biorelate Logo
Series A - Biorelate
—
Manchester Tech Trust Angels Logo
Manchester Tech Trust Angels
—
Series A - Biorelate Logo
Series A - Biorelate
—
Manchester Tech Trust Angels Logo
Manchester Tech Trust Angels
—
Series A - Biorelate Logo
Series A - Biorelate
—
Manchester Tech Trust Angels Logo
Manchester Tech Trust Angels
—
Series A - Biorelate Logo
Series A - Biorelate
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Contacts 21

Employee Profiles

News

News and Press

News•Oct 8, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 5, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 27, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 4, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,251
-54.66%
 in past month

IT Spend

$2.4MThis year, Biorelate is projected to spend $2.4M on IT, according to Aberdeen.

Actively Used Products

14Biorelate uses 14 technology products and services including HTML5, Cloudflare CDN, and  Amazon EC2, according to G2 Stack.

Active Website Tech Count

11Biorelate is actively using 11 technologies for its website, according to BuiltWith. These include DNSSEC, Mobile Non Scaleable Content, and  Express.

Total IP

3Biorelate has registered 3 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Biorelate's headquarters? Biorelate is located in Manchester, Manchester, United Kingdom.Who invested in Biorelate? Biorelate has 8 investors including Manchester Tech Trust Angels and  YFM Equity Partners.When was the last funding round for Biorelate? Biorelate closed its last funding round on
obfuscation
from a Series A round.Who are Biorelate's competitors? Alternatives and possible competitors to Biorelate may include Insilico Medicine, Elicit, and  Causaly.How much funding has Biorelate raised to date? Biorelate has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(61b92bb 1)
|